NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $320,280 | -6.0% | 6,582 | +7.3% | 0.35% | -15.8% |
| Q1 2023 | $340,615 | -93.1% | 6,135 | -86.1% | 0.42% | -78.5% |
| Q3 2021 | $4,911,000 | +10.5% | 44,069 | +12.6% | 1.95% | +35.7% |
| Q2 2021 | $4,444,000 | -10.7% | 39,143 | -21.7% | 1.43% | +17.3% |
| Q4 2020 | $4,976,000 | -1.6% | 50,000 | -28.6% | 1.22% | -18.5% |
| Q3 2020 | $5,057,000 | +278.0% | 70,000 | -31.8% | 1.50% | +152.8% |
| Q1 2019 | $1,338,000 | 0.0% | 102,617 | 0.0% | 0.59% | +3.7% |
| Q4 2018 | $1,338,000 | -26.1% | 102,617 | +25.5% | 0.57% | -7.9% |
| Q3 2018 | $1,811,000 | -26.2% | 81,783 | -36.8% | 0.62% | -31.5% |
| Q2 2018 | $2,454,000 | +82.5% | 129,341 | -10.8% | 0.91% | +64.0% |
| Q1 2018 | $1,345,000 | +62.6% | 145,075 | +57.7% | 0.55% | +54.9% |
| Q4 2017 | $827,000 | -30.3% | 91,993 | 0.0% | 0.36% | -32.6% |
| Q3 2017 | $1,186,000 | +81.3% | 91,993 | +52.8% | 0.53% | +77.9% |
| Q2 2017 | $654,000 | -11.5% | 60,212 | -27.7% | 0.30% | +1.4% |
| Q1 2017 | $739,000 | – | 83,279 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |